Transcription factors in myeloid development: balancing differentiation with transformation
The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.
Abstract
In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, downregulation of PU.1 was identified as a mechanism for the induction of leukemias generated by PML-RARa, FLT3-ITD, and AML1-ETO.[43][44][45]”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [43]
In the citing paper
“PU.1, a non-canonical pioneer transcription factor that functions as a master regulator of myeloid and lymphoid lineage differentiation18–20.”
From Lymphoid gene expression supports neuroprotective microglia function (2025) · cites this paper as [18]
In the citing paper
“Irf8 promotes GM lineage differentiation.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“In particular, Irf8 promotes monocyte differentiation as a lineage switch between monocyte and granulocyte bifurcation29.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [29]
In the citing paper
“All activated macrophages, regardless of polarization state, express high levels of the transcription factors runt-related transcription factor 1 (RUNX1) and PU.1, which are thought to represent global regulators of macrophage phenotypic expression [20–22].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [20]
Citations
Cites
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617 · cited 1×
“The first lymphoid progenitor population that is known to arise from MPPs is the common lymphoid progenitors (CLPs; LIN − IL-7Rα + SCA1 low KIT low”
BackgroundIdentification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Adolfsson, J., Månsson, R., Buza-Vidas, N., Hultquist, A., Liuba, K., Jensen, C. T., Bryder, D., Yang, L., Borge, O.-J., Thoren, L. A. M., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.013 · Cited by 1,236
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Research works printed but not linked: 1
- Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590–1600 (2005). · DOI · Paper page
Cited by
Items 101–200 of 608
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
Eyholzer, M., Schmid, S., Wilkens, L., Mueller, B. U., & Pabst, T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605751 · Cited by 115
“Deregulation of either haematopoietic transcription factors or miRNAs is a common event in the molecular pathogenesis of human leukaemias (Tenen, 2003; Kluiver et al, 2006; Rosenbauer and Tenen, 2007; Fabbri et al, 2008).”
BackgroundComplexity of CEBPA Dysregulation in Human Acute Myeloid Leukemia
Pabst, T., & Mueller, B. U. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2941 · Cited by 114
Weishaupt, H., Sigvardsson, M., & Attema, J. L. (2010) · Blood · doi:10.1182/blood-2009-07-235176 · Cited by 111
Park, I., Mishra, A., Chandler, J. C., Whitman, S. P., Marcucci, G., & Caligiuri, M. A. (2013) · Blood · doi:10.1182/blood-2012-07-444018 · Cited by 109
Chen, M., Lin, H., Shen, C., Ma, Y., Wang, F., Zhao, H.-L., Yu, J., & Zhang, J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00429-15 · Cited by 108
Transcriptional dysregulation during myeloid transformation in AML
Pabst, T., & Mueller, B. U. (2007) · Oncogene · doi:10.1038/sj.onc.1210765 · Cited by 120
“…control of normal myeloid development has recently been extensively summarized (Friedman, 2002; Rosmarin et al., 2005; Mueller and Pabst, 2006; Rosenbauer and Tenen, 2007), as well as elsewhere in this issue, this review intends to highlight aspects of transcriptional dysregulation in human…”
BackgroundHistone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer
Botrugno, O. A., Santoro, F., & Minucci, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.027 · Cited by 114
Jin, H., Li, L., Xu, J., Zhen, F., Zhu, L., Liu, P. P., Zhang, M., Zhang, W., & Wen, Z. (2012) · Blood · doi:10.1182/blood-2011-12-398362 · Cited by 103
Müller‐Tidow, C., Klein, H., Hascher, A., Isken, F., Tickenbrock, L., Thoennissen, N. H., Singh, S. A., Tschanter, P., Disselhoff, C., Wang, Y., et al. (2010) · Blood · doi:10.1182/blood-2009-09-240978 · Cited by 115
Microglia-Mediated Neurodegeneration in Perinatal Brain Injuries
Fleiss, B., Steenwinckel, J. V., Bokobza, C., Shearer, I. K., Ross-Munro, E., & Gressèns, P. (2021) · Biomolecules · doi:10.3390/biom11010099 · Cited by 117
“A subset of these erythromyeloid progenitors, regulated by the expression of PU1, RUNX1 and IRF8, give rise to MG progenitors [31].”
BackgroundTranscriptional control of erythropoiesis: emerging mechanisms and principles
Kim, S.-I., & Bresnick, E. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210761 · Cited by 140
“Dysregulation of signaling and transcriptional mechanisms leads to the development and progression of specific leukemias (Gilliland et al., 2004; Rosenbauer and Tenen, 2007).”
BackgroundBlood Vessel Organoids for Development and Disease
Salewskij, K., & Penninger, J. M. (2023) · Circulation Research · doi:10.1161/circresaha.122.321768 · Cited by 111
Nijnik, A., Clare, S., Hale, C. B., Raisen, C. L., McIntyre, R. E., Yusa, K., Everitt, A. R., Mottram, L., Podrini, C., Lucas, M., et al. (2011) · Blood · doi:10.1182/blood-2011-05-352666 · Cited by 114
“Three reactions were performed: (1) for Mysm1-wild-type allele with primers Mysm1_F and Mysm1_R, (2) for Mysm1-targeted allele with primers Mysm1_F and Cassette_R, and (3) for the -galactosidase reporter cassette using the -gal_F and -gal_R primer pair.”
MethodZhao, L., Glazov, E. A., Pattabiraman, D. R., Alowaidi, F., Zhang, P., Brown, M. A., Leo, P. J., & Gonda, T. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr024 · Cited by 107
“This is consistent with our findings that Myb directly represses several key positive transcriptional regulators of hematopoietic differentiation , including Runx1, Sfpi1, Cebpb and Junb.”
Hegde, V. L., Tomar, S., Jackson, A. R., Rao, R., Yang, X., Singh, U. P., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503037 · Cited by 98
Koya, J., Kataoka, K., Sato, T., Bando, M., Kato, Y., Tsuruta-Kishino, T., Kobayashi, H., Narukawa, K., Miyoshi, H., Shirahige, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms10924 · Cited by 97
Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice
Ramirez-Herrick, A. M., Mullican, S. E., Sheehan, A. M., & Conneely, O. M. (2011) · Blood · doi:10.1182/blood-2010-02-267906 · Cited by 96
MicroRNA-221–222 Regulate the Cell Cycle in Mast Cells
Mayoral, R. J., Pipkin, M. E., Pachkov, M. V., van Nimwegen, E., Rao, A., & Monticelli, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.433 · Cited by 111
Speicher, A. M., Wiendl, H., Meuth, S. G., & Pawlowski, M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0347-z · Cited by 93
Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development
Yamamoto, M., Kato, T., Hotta, C., Nishiyama, A., Kurotaki, D., Yoshinari, M., Takami, M., Ichino, M., Nakazawa, M., Matsuyama, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025812 · Cited by 105
“1 is essential for macrophage differentiation in particular, C/EBPa and C/EBPe are the critical drivers of granulocyte differentiation [3].”
BackgroundCalés, C., Román-Trufero, M., Pavón, L., Serrano, I., Melgar, T., Endoh, M., Pérez, C., Koseki, H., & Vidal, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01136-07 · Cited by 95
“Tissue homeostasis, then, depends on an adequate balance between stem cell renewal, regulated cell proliferation, and terminal differentiation of stem cell progeny (58, 74).”
BackgroundLuminescent detection of DNA-binding proteins
Leung, C., Chan, D. S., He, H., Cheng, Z., Yang, H., & Ma, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr763 · Cited by 100
Pospisil, V., Vargova, K., Kokavec, J., Rybarova, J., Savvulidi, F., Jonasova, A., Necas, E., Zavadil, J., Laslo, P., & Stopka, T. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.317 · Cited by 93
“The successful generation of terminal blood cells is dependent upon coordinated regulation of gene expression by key regulators: transcription factors and microRNAs (Nerlov and Graf, 1998; Orkin and Zon, 2002; Rosenbauer and Tenen, 2007; Garzon and Croce, 2008).”
BackgroundPLZF is a regulator of homeostatic and cytokine-induced myeloid development
Doulatov, S., Notta, F., Rice, K. L., Howell, L., Zelent, A., Licht, J. D., & Dick, J. E. (2009) · Genes & Development · doi:10.1101/gad.1788109 · Cited by 93
“Proper regulation ensures an adequate supply of mature cells, while leukemogenesis and other myeloid malignancies are often driven by inappropriate activity of these transcription factors (Rosenbauer and Tenen 2007).”
BackgroundEnforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways
Surdziel, E., Cabanski, M., Dallmann, I., Łyszkiewicz, M., Krueger, A., Ganser, A., Scherr, M., & Eder, M. (2011) · Blood · doi:10.1182/blood-2010-06-289058 · Cited by 98
“Members of the Bcl2 family, such as Bak1, Bmf and PUMA are predicted and/or validated targets for miR125b.20,21,34 However, we failed to detect repression of BMF and PUMA in 32D/miR-125b cells (data not shown).”
MethodInfluentialFigueroa, M. E., Wouters, B. J., Skrabanek, L., Glass, J., Li, Y., Erpelinck-Verschueren, C. A. J., Langerak, A. W., Löwenberg, B., Fazzari, M., Greally, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172387 · Cited by 91
Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression
Xu, Y., Yan, J., Tao, Y., Qian, X., Zhang, C., Yin, L., Gu, P., Liu, Y., Pan, Y., Tang, R., et al. (2022) · Science · doi:10.1126/science.abj2674 · Cited by 106
The cell of origin and the leukemia stem cell in acute myeloid leukemia
Chopra, M., & Bohlander, S. K. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22805 · Cited by 115
Roles of Neutrophils in Glioma and Brain Metastases
Lin, Y.-J., Wei, K., Chen, P., Lim, M. K., & Hwang, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701383 · Cited by 93
“Neutrophils undergo maturation in the following steps: the formation of myeloblasts, followed by the formation of promyelocytes, myelocytes, metamyelocytes, band neutrophils, and segmented neutrophils (Figure 1) (22, 26, 27).”
BackgroundMeta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations
Mabbott, N. A., Kenneth Baillie, J., Hume, D. A., & Freeman, T. C. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.012 · Cited by 77
Hughes, J. M., Legnini, I., Salvatori, B., Masciarelli, S., Marchioni, M., Fazi, F., Morlando, M., Bozzoni, I., & Fatica, A. (2015) · Oncotarget · doi:10.18632/oncotarget.4069 · Cited by 96
“One of the key components that have been shown to be crucial for myeloid differentiation is the transcription factor CCAAT/enhancer-binding protein-α (C/EBPα) (reviewed in [2]).”
Melo-Cardenas, J., Xu, Y., Wei, J., Tan, C., Kong, S., Gao, B., Montauti, E., Kirsammer, G., Licht, J. D., Yu, J., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811760 · Cited by 84
Monocyte and macrophage biology: an overview
Rees, A. J. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.03.002 · Cited by 84
Bakshi, R., Hassan, M. Q., Pratap, J., Lian, J. B., Montecino, M. A., van Wijnen, A. J., Stein, J. L., Imbalzano, A. N., & Stein, G. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22240 · Cited by 83
MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases
Paşca, S., Jurj, A. M., Petrushev, B., Tomuleasa, C., & Matei, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00625 · Cited by 91
Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension
Shah, K. H., Shi, P. D., Giani, J. F., Janjulia, T., Bernstein, E. A., Li, Y., Zhao, T. V., Harrison, D. G., Bernstein, K. E., & Shen, X. Z. (2015) · Circulation Research · doi:10.1161/circresaha.115.306539 · Cited by 93
“C/EBPα is the key factor in driving myeloid differentiation.(17) C/EBPβ is required for emergent granulopoiesis and the formation of MDSCs.”
BackgroundNew Advances and Contributions to Fish Biology
Türker, H. (2012) · InTech eBooks · doi:10.5772/45635 · Cited by 86
Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo
Tarumoto, Y., Lin, S., Wang, J., Milazzo, J. P., Xu, Y., Lu, B., Yang, Z., Wei, Y., Polyanskaya, S., Wunderlich, M., et al. (2020) · Blood · doi:10.1182/blood.2019001576 · Cited by 79
Liang, D., Liu, H., Yang, C., Jaing, T., Hung, I., Yeh, T., Chen, S., Hou, J., Huang, Y., Shih, Y., et al. (2013) · Blood · doi:10.1182/blood-2012-06-436782 · Cited by 89
Costa, G., Mazan, A., Gandillet, A., Pearson, S., Lacaud, G., & Kouskoff, V. (2012) · Development · doi:10.1242/dev.071282 · Cited by 87
Pundhir, S., Bratt Lauridsen, F. K., Schuster, M. B., Jakobsen, J. S., Ge, Y., Schoof, E. M., Rapin, N., Waage, J., Hasemann, M. S., & Porse, B. T. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.012 · Cited by 77
“1 and CEBPA are key TFs during GM-lineage (myeloid) differentiation (Rosenbauer and Tenen, 2007).”
BackgroundVariant to function mapping at single-cell resolution through network propagation
Yu, F., Cato, L. D., Weng, C., Liggett, L. A., Jeon, S., Xu, K., Chiang, C. W. K., Wiemels, J. L., Weissman, J. S., de Smith, A. J., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01341-y · Cited by 75
“These TFs play important roles in inflammation-induced myelopoiesis 40 and monocyte differentiation 41 .”
BackgroundA longitudinal single-cell atlas of treatment response in pediatric AML
Lambo, S., Trinh, D. L. N., Ries, R. E., Jin, D., Setiadi, A., Ng, M. S. W., Leblanc, V., Loken, M. R., Brodersen, L. E., Dai, F., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.10.008 · Cited by 84
Genetic and environmental pathways to complex diseases
Gohlke, J. M., Thomas, R., Zhang, Y., Rosenstein, M. C., Davis, A. P., Murphy, C. G., Becker, K. G., Mattingly, C. J., & Portier, C. J. (2009) · BMC Systems Biology · doi:10.1186/1752-0509-3-46 · Cited by 80
“1, an ETS like tf, are important in cell fate programs in hematopoesis, particularly in the monocyte/macrophage lineage [46,47].”
Twist-2 Controls Myeloid Lineage Development and Function
Sharabi, A. B., Aldrich, M., Sosic, D., Olson, E. N., Friedman, A. D., Lee, S.-H., & Chen, S.-Y. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060316 · Cited by 74
Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb
Grabher, C., Payne, E. M., Johnston, A. B., Bolli, N., Lechman, E. R., Dick, J. E., Kanki, J. P., & Look, A. T. (2010) · Leukemia · doi:10.1038/leu.2010.280 · Cited by 80
EVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function
Laricchia-Robbio, L., Premanand, K., Rinaldi, C. R., & Nucifora, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2562 · Cited by 73
“Top left, HA-EVI1, HA-EVI1(1-283), and HA-EVI1(159-283) interact with PU.”
BackgroundMethodInfluentialFurusawa, J.-I., Mizoguchi, I., Chiba, Y., Hisada, M., Kobayashi, F., Yoshida, H., Nakae, S., Tsuchida, A., Matsumoto, T., Ema, H., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005507 · Cited by 73
C/EBPα deregulation as a paradigm for leukemogenesis
Pulikkan, J. A., Tenen, D. G., & Behre, G. (2017) · Leukemia · doi:10.1038/leu.2017.229 · Cited by 79
“Molecular and cellular biology 1998 Jan; 18(1): 322-333.”
InfluentialSelf-citationInflammatory signals directly instruct PU.1 in HSCs via TNF
Etzrodt, M., Ahmed, N., Hoppe, P. S., Loeffler, D., Skylaki, S., Hilsenbeck, O., Kokkaliaris, K. D., Kaltenbach, H.-M., Stelling, J., Nerlov, C., et al. (2019) · Blood · doi:10.1182/blood-2018-02-832998 · Cited by 67
Leukemia Stem Cells in Acute Myeloid Leukemia
Chan, W.-I., & Huntly, B. J. P. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.003 · Cited by 87
Ji, M. H., Li, H., Suh, H. C., Klarmann, K. D., Yokota, Y., & Keller, J. R. (2008) · Blood · doi:10.1182/blood-2008-01-133504 · Cited by 85
Forrester, A. M., Grabher, C., McBride, E. R., Boyd, E. R., Vigerstad, M. H., Edgar, A., Kai, F., Da'as, S. I., Payne, E. M., Look, A. T., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08810.x · Cited by 75
“SPI1 (also known as PU.1) is an ETS family transcription factor involved in mammalian myelopoiesis, B-cell lymphopoiesis, and maintenance of haematopoietic stem cells (HSCs) (reviewed in Rosenbauer & Tenen, 2007).”
BackgroundGarner, H., Martinovic, M., Liu, N. Q., Bakker, N. A. M., Velilla, I. Q., Hau, C., Vrijland, K., Kaldenbach, D., Kok, M., de Wit, E., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.04.007 · Cited by 74
Lu, T., Kobayashi, S. D., Quinn, M. T., & DeLeo, F. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00365 · Cited by 79
“During maturation, these cells acquire key functional attributes, including the ability to phagocytose and kill microorganisms (Bainton et al., 1971; Glasser and Fiederlein, 1987; Weissman et al., 2001; Rosenbauer and Tenen, 2007; Pillay et al., 2010).”
BackgroundTranscriptional determination and functional specificity of myeloid cells: making sense of diversity
Monticelli, S., & Natoli, G. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.51 · Cited by 72
Zardo, G., Cimino, G. G., & Nervi, C. (2008) · Leukemia · doi:10.1038/leu.2008.141 · Cited by 74
Wölfler, A., Oorschot, A. A. D.-V., Haanstra, J. R., Valkhof, M. G., Bodner, C., Vroegindeweij, E. M., van Strien, P., Novak, A., Cupedo, T., & Touw, I. P. (2010) · Blood · doi:10.1182/blood-2010-03-275404 · Cited by 71
Erythroid and megakaryocytic transformation
Wickrema, A., & Crispino, J. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210763 · Cited by 80
Dyer, M. J. S., Akasaka, T., Capasso, M., Dusanjh, P., Lee, Y. F., Karran, E. L., Nagel, I., Vater, I., Cario, G., & Siebert, R. (2009) · Blood · doi:10.1182/blood-2009-09-235986 · Cited by 71
Xiao, Y., Zijl, S., Wang, L., de Groot, D. C., van Tol, M. J., Lankester, A. C., & Borst, J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.04.012 · Cited by 62
How the niche regulates hematopoietic stem cells
Renström, J., Kröger, M., Peschel, C., & Oostendorp, R. A. J. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.11.012 · Cited by 82
Shen, C., Chen, M.-T., Zhang, X.-H., Yin, X.-L., Ning, H.-M., Su, R., Lin, H.-S., Song, L., Wang, F., Ma, Y.-N., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006259 · Cited by 62
“Hematopoiesis is a highly ordered multistep process that is orchestrated by various regulators including transcriptional factors [1], cytokines [2], and noncoding RNAs [3].”
BackgroundRetractedTay, T. L., Carrier, M., & Tremblay, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_6 · Cited by 63
Huber, R., Pietsch, D., Günther, J., Welz, B., Vogt, N., & Brand, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1322-4 · Cited by 70
“Thus, the number of HSC in the stem cell pool is preserved [6] and the development of a series of myeloid and lymphoid progenitors without self-renewal potential, but characterized by (decreasing) proliferative and (increasing) differentiating capacity, is enabled [9].”
BackgroundInfluentialTranscription factors in myeloid-derived suppressor cell recruitment and function
Sonda, N., Chioda, M., Zilio, S., Simonato, F., & Bronte, V. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.12.006 · Cited by 65
Morris, V., Zhang, A., Yang, T., Stirewalt, D. L., Ramamurthy, R., Meshinchi, S., & Oehler, V. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075815 · Cited by 67
“Additionally QPCR validation studies demonstrated at least a two-fold reduction in expression of IRF8, an important myeloid transcription factor [7], in miR-150 expressing cells vs.”
MethodC/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia
Alberich-Jordà, M., Wouters, B., Balastik, M., Shapiro-Koss, C., Zhang, H., DiRuscio, A., Radomska, H. S., Ebralidze, A. K., Amabile, G., Ye, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65102 · Cited by 59
“The hematopoietic system, due to its well characterized cell hierarchy and well defined cell types, has been extensively used to study the function of transcription factors in cell renewal and differentiation (1, 2).”
Self-citationIn vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis
Lara‐Astiaso, D., Goñi‐Salaverri, A., Mendieta-Esteban, J., Narayan, N., del Valle, C., Groß, T., Giotopoulos, G., Beinortas, T., Navarro-Alonso, M., Aguado‐Alvaro, L. P., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01471-2 · Cited by 63
Hamid, R., & Brandt, S. J. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.07.004 · Cited by 56
“Since increased expression of CEBPb, CEBP3, PU.1, RUNX1 and ZFPM1 and decreased expression of c-MYB are required for proper myeloid differentiation (Rosenbauer and Tenen, 2007), these data suggest that alteration in this transcriptional program may be, in part, responsible for the decreased…”
BackgroundMethodMLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program
Xu, J., Li, L., Xiong, J., denDekker, A. D., Ye, A., Karataş, H., Liu, L., Wang, H., Qin, Z. S., Wang, S., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.8 · Cited by 65
Pulikkan, J. A., Dengler, V., Zada, A. A. P., Kawasaki, A., Geletu, M., Pasalic, Z., Bohlander, S. K., Ryo, A., Tenen, D. G., & Behre, G. (2010) · Leukemia · doi:10.1038/leu.2010.37 · Cited by 62
Self-citationKreher, S., Bouhlel, M. A., Cauchy, P., Lamprecht, B., Li, S., Grau, M., Hummel, F., Köchert, K., Anagnostopoulos, I., Jöhrens, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406985111 · Cited by 60
Interferon regulatory factor signaling in autoimmune disease
Matta, B., Song, S., Li, D., & Barnes, B. J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.02.006 · Cited by 61
“IRF8 is a key transcription factor for myeloid cell differentiation [58].”
BackgroundNA-Seq: A Discovery Tool for the Analysis of Chromatin Structure and Dynamics during Differentiation
Gargiulo, G., Levy, S., Bucci, G., Romanenghi, M., Fornasari, L., Beeson, K. Y., Goldberg, S. M. D., Cesaroni, M., Ballarini, M., Santoro, F., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.02.002 · Cited by 56
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
Zhou, J., Wu, J., Li, B., Liu, D., Yu, J., Yan, X., Zheng, S., Wang, J., Zhang, L., Zhang, L., et al. (2014) · Leukemia · doi:10.1038/leu.2013.384 · Cited by 53
Self-citationB- myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development
Baker, S. J., Ma’ayan, A., Lieu, Y. K., John, P., Reddy, M. V. R., Chen, E. Y., Duan, Q., Snoeck, H.-W., & Reddy, E. P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315464111 · Cited by 53
“ID1, GATA2, and CEBPα are transcription factors that regulate HSC development as well as various stages of myeloid lineage commitment (42).”
BackgroundWang, W., Schwemmers, S., Hexner, E. O., & Pahl, H. L. (2010) · Blood · doi:10.1182/blood-2009-11-254664 · Cited by 63
Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models
DeKoter, R. P., Kamath, M. B., & Houston, I. B. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.004 · Cited by 63
Paschall, A. V., Zhang, R., Qi, C.-F., Bardhan, K., Peng, L., Lu, G., Yang, J., Merad, M., McGaha, T., Zhou, G., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402412 · Cited by 52
Regulation of the MIE Locus During HCMV Latency and Reactivation
Dooley, A. L., & O’Connor, C. M. (2020) · Pathogens · doi:10.3390/pathogens9110869 · Cited by 55
“Cell fate and differentiation are tightly regulated by cellular gene expression in the myeloid lineage [60], suggesting the same sets of transcription factors and chromatin-modifying enzymes may be involved.”
BackgroundGene mutations and molecularly targeted therapies in acute myeloid leukemia.
Hatzimichael, E. C., Georgiou, G. K., Benetatos, L., & Briasoulis, E. C. (2013) · Europe PMC (PubMed Central) · Cited by 64
Haefliger, S., Klebig, C., Schaubitzer, K., Schardt, J., Timchenko, N. A., Mueller, B. U., & Pabst, T. (2011) · Blood · doi:10.1182/blood-2010-08-304485 · Cited by 60
Pendino, F., Nguyen, E., Jonassen, I., Dysvik, B., Azouz, A., Lanotte, M., Ségal-Bendirdjian, E., & Lillehaug, J. R. (2009) · Blood · doi:10.1182/blood-2008-07-170035 · Cited by 51
Nuclear microRNAs in normal hemopoiesis and cancer
Rasko, J. E. J., & Wong, J. J. L. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0375-x · Cited by 54
“Lineage commitment towards blood cell production begins with the hemopoietic stem cell escaping quiescence and the stepwise acquisition of specific myeloid or lymphoid identities [49, 50].”
BackgroundNussinov, R., Yavuz, B. R., Arici, M. K., Demirel, H. C., Zhang, M., Liu, Y., Tsai, C., Jang, H., & Tunçbağ, N. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01054-9 · Cited by 49
“Transcription factors can stimulate differentiation and lead to cell cycle arrest, and this double action has been exploited to treat leukemia (Rosenbauer and Tenen, 2007).”
BackgroundDevelopment of macrophages of cyprinid fish
Hanington, P. C., Tam, J., Katzenback, B. A., Hitchen, S. J., Barreda, D. R., & Belosevic, M. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.11.004 · Cited by 53
“macrophage differentiation [89,96,97].”
Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease
Beckman, J. D., Belcher, J. D., Vineyard, J. V., Chen, C., Nguyen, J., Nwaneri, M. O., O’Sullivan, M. G., Gulbahce, E. H., Hebbel, R. P., & Vercellotti, G. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2009 · Cited by 51
New insights into SMA pathogenesis: immune dysfunction and neuroinflammation
Deguise, M., & Kothary, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.423 · Cited by 58
Modulation of vitamin D signaling by the pioneer factor CEBPA
Nurminen, V., Neme, A., Seuter, S., & Carlberg, C. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.12.004 · Cited by 53
“They are widely expressed in many tissues and cell types and control a number of cellular processes, such as cellular proliferation and differentiation, inflammation and metabolism [2].”
BackgroundThe “Janus” Role of C/EBPs Family Members in Cancer Progression
Tolomeo, M., & Grimaudo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124308 · Cited by 56
ERO1-PDI Redox Signaling in Health and Disease
Jha, V., Kumari, T., Manickam, V., Assar, Z., Olson, K. L., Min, J., & Cho, J. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0018 · Cited by 52
Chambers, C., Čermáková, K., Chan, Y. S., Kurtz, K. J., Wohlan, K., Lewis, A. H., Wang, C., Pham, A., Dejmek, M., Šála, M., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2129 · Cited by 56
“An important hallmark of AML cell identity is a deregulated hematopoietic transcriptional program that promotes malignant self-renewal and impairs differentiation (4).”
Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance
Scheller, M., Schönheit, J., Zimmermann, K., Leser, U., Rosenbauer, F., & Leutz, A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130706 · Cited by 48
“Although myeloerythroid transcriptional deregulation is often associated with leukemogenesis, it may thus be considered as a consequence, rather than the cause of malignancy (Jamieson et al., 2004; Rosenbauer and Tenen, 2007).”
BackgroundSelf-citationConvergent epigenetic evolution drives relapse in acute myeloid leukemia
Nuno, K. A., Azizi, A., Köhnke, T., Lareau, C. A., Ediriwickrema, A., Corces, M. R., Satpathy, A. T., & Majeti, R. (2024) · eLife · doi:10.7554/elife.93019 · Cited by 52
“Conversely, we observed an enrichment of FOXO family factors in the stable relapse samples, as well as the GATA family (known regulators of early progenitors in hematopoietic development) and E2F ( Rosenbauer and Tenen, 2007 ).”
H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia
Kawahara, M., Pandolfi, A., Bartholdy, B., Barreyro, L., Will, B., Roth, M. E., Okoye-Okafor, U. C., Todorova, T. I., Figueroa, M. E., Melnick, A. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.027 · Cited by 55
“See also Figure S6 and Table S3 for addition Several transcription factors that govern normal hematopoietic differentiation have been implicated in leukemogenesis by blocking differentiation and promoting self-renewal and clonogenicity (for review, see Rosenbauer and Tenen, 2007).”
Leukemia and hematopoietic stem cells: Balancing proliferation and quiescence
Jude, C. D., Gaudet, J., Speck, N. A., & Ernst, P. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5549 · Cited by 50
Ren, M., Qin, H., Kitamura, E., & Cowell, J. K. (2013) · Blood · doi:10.1182/blood-2013-03-489823 · Cited by 51
Inactivation of the p53–KLF4–CEBPA Axis in Acute Myeloid Leukemia
Seipel, K., Marques, M. T., Bozzini, M.-A., Meinken, C., Mueller, B. U., & Pabst, T. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1054 · Cited by 49
“CCAAT/enhancer-binding protein alpha (CEBPA) is a lineagespecific transcription factor expressed in hematopoietic stem and myeloid progenitor cells (1).”
BackgroundRUNX1 cooperates with FLT3-ITD to induce leukemia
Behrens, K., Maul, K., Tekin, N. S., Kriebitzsch, N., Indenbirken, D., Prassolov, V., Müller, U., Serve, H. L., Cammenga, J., & Stocking, C. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160927 · Cited by 48
“…interplay of RUNX1 with several granulocyte/macrophage (G/M) transcription factors (TFs; e.g., C/EBP, PU.1, and GFI1) during normal myelopoiesis (Rosenbauer and Tenen, 2007), and thus, a popular theory is that reduced levels of RUNX1 activity contributes to the myeloid differentiation block in…”
Background
Metadata
- Authors
- Rosenbauer, F., & Tenen, D. G.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 105-117
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1980860344
- Cited by
- 606
- References
- 142
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 21 · 2023: 24 · 2022: 29 · 2021: 17 · 2020: 21 · 2019: 28 · 2018: 30 · 2017: 45 · 2016: 31 · 2015: 42 · 2014: 38 · 2013: 43 · 2012: 27
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- Lymphoma Research Foundation
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- transcription factors, myeloid development, myeloid differentiation, myeloid leukemia, differentiation block, transcription factor dysregulation, cell fate regulation
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Hematopoietic Stem Cells, Humans, Leukemia, Myeloid, Transcription Factors, Mice, Knockout, Cell Lineage, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.